Century Therapeutics IPSC
NASDAQ IPSC
$1.65 -0.02 (-1.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Short term Debt (2021 - 2023)

Updated

Century Therapeutics' Short term Debt came in at $10.3 million for Q1 2023, up 58.4% from the prior quarter.

Analysis

Century Therapeutics (IPSC) Short term Debt (2021 - 2023) Analysis & Trends

At the end of FY2022, Century Therapeutics' Short term Debt was $6.5 million, up 525.8% from FY2021.

  • Going back by year, Short term Debt was $1.04 million in FY2021.
  • Business Quant data shows IPSC's Short term Debt at $6.5 million (Q4 2022), $4.04 million (Q3 2022) and $1.59 million (Q2 2022) in the three quarters before Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Century Therapeutics 301.51 Mn -202.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 10.30 Mn
Dec 31, 2022 6.50 Mn
Sep 30, 2022 4.04 Mn
Jun 30, 2022 1.59 Mn
Dec 31, 2021 1.04 Mn
API Access

Century Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=IPSC&period=max&api_key=YOUR_API_KEY